Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

HISTORICAL FACTS: 4 - The Untold Story

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022

Upgrades

Benzinga

Amazon To $160? These Analysts Cut Price Targets On Amazon After Q3 Results

Amazon.com, Inc. (NASDAQ: AMZN) reported upbeat earnings for its third quarter, while sales missed estimates. The company also issued weak sales forecast for the fourth quarter.

Benzinga

Meta Platforms To $200? These Analysts Slash Price Targets On Meta Following Q3 Results

Meta Platforms, Inc. (NASDAQ: META) reported worse-than-expected Q3 EPS and issued Q4 revenue guidance with a midpoint below estimates. The company also guided FY23 expenses of $96 billion to $101 billion. Meta Platforms shares dropped 22.1% to $101.20 on Thursday.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022

Upgrades

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022

Upgrades

Benzinga

Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Sunlight Financial Shares Are Trading Lower By 59%, Here Are 54 Stocks Moving In Thursday's Mid-Day Session

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares jumped 52% to $2.1325 after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022

Upgrades

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2022

Benzinga

Exxon Mobil Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on Exxon Mobil. Looking at options history for Exxon Mobil (NYSE:XOM) we detected 63 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022

Upgrades

1 … 3 4 5 6

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.